Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Cell Cycle (Georgetown, Tex.)
|
July 20, 2011
Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells
Ubaldo E Martinez-Outschoorn, Zhao Lin, Ying-Hui Ko, et al.
Cell Cycle (Georgetown, Tex.)
|
March 8, 2012
Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue
Federica Sotgia, Diana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, et al.
Cell Cycle (Georgetown, Tex.)
|
September 7, 2010
Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism
Gloria Bonuccelli, Aristotelis Tsirigos, Diana Whitaker-Menezes, et al.
Aging
|
May 6, 2010
Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
Stephanos Pavlides, Aristotelis Tsirigos, Iset Vera, et al.
Seminars in Oncology
|
February 24, 2005
Cytoprotection in acute myelogenous leukemia (AML) therapy
Dolores Grosso, Joanne Filicko, Guillermo Garcia-Manero, et al.
Bone Marrow Transplantation
|
June 17, 2018
Final outcomes of escalated melphalan 280 mg/m<sup>2</sup> with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Parameswaran Hari, Donna E Reece, Jasleen Randhawa, et al.
Cell Cycle (Georgetown, Tex.)
|
April 23, 2011
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics
Ubaldo E Martinez-Outschoorn, Marco Prisco, Adam Ertel, et al.
Transplantation and Cellular Therapy
|
April 10, 2021
An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation
Chetan Jeurkar, Benjamin Leiby, Joshua Banks, et al.
Cell Cycle (Georgetown, Tex.)
|
June 22, 2010
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling
Gemma Migneco, Diana Whitaker-Menezes, Barbara Chiavarina, et al.
Cell Cycle (Georgetown, Tex.)
|
June 4, 2010
Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation
Stephanos Pavlides, Aristotelis Tsirigos, Iset Vera, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Cell Cycle (Georgetown, Tex.)
|
July 20, 2011
Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells
Ubaldo E Martinez-Outschoorn, Zhao Lin, Ying-Hui Ko, et al.
Cell Cycle (Georgetown, Tex.)
|
March 8, 2012
Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue
Federica Sotgia, Diana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, et al.
Cell Cycle (Georgetown, Tex.)
|
September 7, 2010
Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism
Gloria Bonuccelli, Aristotelis Tsirigos, Diana Whitaker-Menezes, et al.
Aging
|
May 6, 2010
Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
Stephanos Pavlides, Aristotelis Tsirigos, Iset Vera, et al.
Seminars in Oncology
|
February 24, 2005
Cytoprotection in acute myelogenous leukemia (AML) therapy
Dolores Grosso, Joanne Filicko, Guillermo Garcia-Manero, et al.
Bone Marrow Transplantation
|
June 17, 2018
Final outcomes of escalated melphalan 280 mg/m<sup>2</sup> with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Parameswaran Hari, Donna E Reece, Jasleen Randhawa, et al.
Cell Cycle (Georgetown, Tex.)
|
April 23, 2011
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics
Ubaldo E Martinez-Outschoorn, Marco Prisco, Adam Ertel, et al.
Transplantation and Cellular Therapy
|
April 10, 2021
An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation
Chetan Jeurkar, Benjamin Leiby, Joshua Banks, et al.
Cell Cycle (Georgetown, Tex.)
|
June 22, 2010
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling
Gemma Migneco, Diana Whitaker-Menezes, Barbara Chiavarina, et al.
Cell Cycle (Georgetown, Tex.)
|
June 4, 2010
Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation
Stephanos Pavlides, Aristotelis Tsirigos, Iset Vera, et al.
Page
of 8